Ziraoui, N.-E., Salazar, M. and Kensington, A. (2026) “BCLC™ NAD⁺ Supplement System Targeting SIRT1: A Time-Sequential Biphasic NMN-Resveratrol-Quercetin Formulation with Supporting Clinical and Pharmacological Evidence”, International Journal of Public Health and Medical Research, 6(4), pp. 36–44. doi:10.62051/ijphmr.v6n4.06.